[Pathogenesis of idiopathic pulmonary fibrosis]
- PMID: 7615308
[Pathogenesis of idiopathic pulmonary fibrosis]
Abstract
Idiopathic pulmonary fibrosis or lone cryptogenic fibrosing alveolitis is an interstitial lung disease of unknown origin carrying an unfavorable prognosis. A yet unidentified hazard triggers a chronic inflammatory infiltration of the lung parenchyma characterized by an accumulation of alveolar macrophages, neutrophil and eosinophil granulocytes, and lymphocytes. Cytokines released by the activated cells modulate the inflammatory events. Oxidants and proteases, mainly released by alveolar macrophages and neutrophil granulocytes, mediate the injury to the lung parenchyma, leading to loss of alveolar-capillary units. The ensuing repair process, mesenchymal cell proliferation and up-regulation of synthesis of collagen fibers and other components of connective tissue matrix, replaces lung parenchyma by fibrotic tissue, leading to irreversible pulmonary dysfunction.
Similar articles
-
[Pathogenesis of idiopathic interstitial pneumonia/idiopathic pulmonary fibrosis: cellular and molecular biology of the disease].Nihon Kyobu Shikkan Gakkai Zasshi. 1993 Dec;31 Suppl:20-31. Nihon Kyobu Shikkan Gakkai Zasshi. 1993. PMID: 8007466 Review. Japanese.
-
[Biopathology of fibrosing alveolitis].Rev Prat. 1991 May 11;41(14):1247-52. Rev Prat. 1991. PMID: 2068515 Review. French.
-
[Idiopathic pulmonary fibrosis: from biopathology to treatment].Rev Prat. 2000 Nov 1;50(17):1906-10. Rev Prat. 2000. PMID: 11151332 French.
-
Presence of platelet-derived growth factor in normal and fibrotic lung is specifically associated with interstitial macrophages, while both interstitial macrophages and alveolar epithelial cells express the c-sis proto-oncogene.Am J Respir Cell Mol Biol. 1991 Dec;5(6):531-8. doi: 10.1165/ajrcmb/5.6.531. Am J Respir Cell Mol Biol. 1991. PMID: 1958380
-
Structural features of interstitial lung disease in systemic sclerosis.Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):706-13. doi: 10.1164/ajrccm/144.3_Pt_1.706. Am Rev Respir Dis. 1991. PMID: 1892314
Cited by
-
Rhoifolin improves bleomycin-induced fibrosis in vivo and cell damage in vitro both related to NRF2/HO-1 pathway.BMC Pulm Med. 2025 Mar 14;25(1):117. doi: 10.1186/s12890-025-03526-y. BMC Pulm Med. 2025. PMID: 40087614 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical